93 related articles for article (PubMed ID: 21333432)
1. The determinants of the adoption of pharmaceutical innovation: evidence from Taiwan.
Liu YM; Yang YH; Hsieh CR
Soc Sci Med; 2011 Mar; 72(6):919-27. PubMed ID: 21333432
[TBL] [Abstract][Full Text] [Related]
2. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
3. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
Liu YM; Yang YH; Hsieh CR
J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
[TBL] [Abstract][Full Text] [Related]
4. Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
Lee YC; Huang KH; Huang YT
Health Policy Plan; 2007 Nov; 22(6):427-35. PubMed ID: 17901065
[TBL] [Abstract][Full Text] [Related]
5. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
Liu YM; Ou HT; Yang YK
J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
[TBL] [Abstract][Full Text] [Related]
6. Regulation and competition in the Taiwanese pharmaceutical market under national health insurance.
Liu YM; Yang YH; Hsieh CR
J Health Econ; 2012 May; 31(3):471-83. PubMed ID: 22525716
[TBL] [Abstract][Full Text] [Related]
7. Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.
Hsiao FY; Tsai YW; Huang WF
Clin Ther; 2009 Nov; 31(11):2618-27. PubMed ID: 20110006
[TBL] [Abstract][Full Text] [Related]
8. Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan.
Gau CS; Chang IS; Lin Wu FL; Yu HT; Huang YW; Chi CL; Chien SY; Lin KM; Liu MY; Wang HP
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):86-95. PubMed ID: 17006967
[TBL] [Abstract][Full Text] [Related]
9. Changes in prescribing behaviors after implementing drug reimbursement rate reduction policy in Taiwan: implications for the medicare system.
Chu HL; Liu SZ; Romeis JC
J Health Care Finance; 2008; 34(3):45-54. PubMed ID: 18468378
[TBL] [Abstract][Full Text] [Related]
10. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
11. The adoption of pharmaceutical innovation and its impact on the treatment costs for Alzheimer's disease in Taiwan.
Lo TF; Hsieh CR
J Ment Health Policy Econ; 2014 Sep; 17(3):107-17. PubMed ID: 25543114
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
13. Determinants for the adoption of angiotensin II receptor blockers by general practitioners.
Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; Haaijer-Ruskamp FM
Soc Sci Med; 2006 Dec; 63(11):2890-8. PubMed ID: 16959390
[TBL] [Abstract][Full Text] [Related]
14. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
15. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
[TBL] [Abstract][Full Text] [Related]
16. New drugs and the growth of health expenditure: evidence from diabetic patients in Taiwan.
Liu YM; Hsieh CR
Health Econ; 2012 May; 21(5):496-513. PubMed ID: 21394819
[TBL] [Abstract][Full Text] [Related]
17. Dental screening and referral of young children by pediatric primary care providers.
dela Cruz GG; Rozier RG; Slade G
Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
[TBL] [Abstract][Full Text] [Related]
18. Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement.
Verger P; Rolland S; Paraponaris A; Bouvenot J; Ventelou B
Fundam Clin Pharmacol; 2010 Aug; 24(4):509-16. PubMed ID: 19840120
[TBL] [Abstract][Full Text] [Related]
19. Determinants of generic entry in the regulated Taiwanese prescription drug market.
Liu YM; Cheng JS
Health Policy; 2012 Dec; 108(2-3):228-35. PubMed ID: 23020970
[TBL] [Abstract][Full Text] [Related]
20. Generic medicines: Greek physicians' perceptions and prescribing practices.
Tsiantou V; Zavras D; Kousoulakou H; Geitona M; Kyriopoulos J
J Clin Pharm Ther; 2009 Oct; 34(5):547-54. PubMed ID: 19744010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
